Immunome Inc. (IMNM) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$212.39M | +27.5% |
| 2024 | -$292.96M | -174.3% |
| 2023 | -$106.81M | -189.5% |
| 2022 | -$36.90M | -49.3% |
| 2021 | -$24.71M | -38.5% |
| 2020 | -$17.84M | -70.8% |
| 2019 | -$10.44M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$212.39M | +27.5% |
| 2024 | -$292.96M | -174.3% |
| 2023 | -$106.81M | -189.5% |
| 2022 | -$36.90M | -49.3% |
| 2021 | -$24.71M | -38.5% |
| 2020 | -$17.84M | -70.8% |
| 2019 | -$10.44M | — |